tony w
BMC Musculoskeletal Disorders
Trials
Acta Neurochirurgica
The Journal of Headache and Pain
The Journal of Headache and Pain
BMC Nursing
International Journal of Nursing Studies
People with heart disease who choose to eat from the Mediterranean diet food groups are less likely to have a heart-related event, a new study suggests.
Faith is blind when we believe in something unseen without any or sufficient evidence. Underlying many of our actions is our belief that it will lead to the desired goal.Many people act as if they don’t believe (or accept) that exercise and a balanced diet lead to better health and a sense of well-being (although evidence exists). It is as if…
(This April 28 story corrects the fifth paragraph to say that two, not one, other diabetes drugs have positive cardiovascular side-effects) COPENHAGEN (Reuters) – Novo Nordisk said on Thursday a late-stage trial showed its new once-weekly diabetes drug significantly reduced patients’ cardiovascular risks, boosting the company’s hopes of maintaining its lead in the fast-growing diabetes market. The trial, dubbed SUSTAIN 6, showed the drug – called semaglutide – delivered a “statistically significant reduction in cardiovascular risk” compared with placebo in patients with type 2 diabetes. Cardiovascular risks are often higher among diabetes patients because they tend to be overweight.